Platt-Higgins A - Search Results

1

Ran is a potential therapeutic target for cancer cells with molecular changes associated with activation of the PI3K/Akt/mTORC1 and Ras/MEK/ERK pathways.

Yuen HF, Chan KK, Grills C, Murray JT, Platt-Higgins A, Eldin OS, O'Byrne K, Janne P, Fennell DA, Johnston PG, Rudland PS, El-Tanani M. Yuen HF, et al. Clin Cancer Res. 2012 Jan 15;18(2):380-91. doi: 10.1158/1078-0432.CCR-11-2035. Epub 2011 Nov 16. Clin Cancer Res. 2012. PMID: 22090358 Free PMC article.

2

The long term prognostic significance of c-erbB-2 in primary breast cancer.

Winstanley J, Cooke T, Murray GD, Platt-Higgins A, George WD, Holt S, Myskov M, Spedding A, Barraclough BR, Rudland PS. Winstanley J, et al. Br J Cancer. 1991 Mar;63(3):447-50. doi: 10.1038/bjc.1991.103. Br J Cancer. 1991. PMID: 1672256 Free PMC article.

3

Immunolocalization of alpha-transforming growth factor in the developing rat mammary gland in vivo, rat mammary cells in vitro and in human breast diseases.

McAndrew J, Rudland PS, Platt-Higgins AM, Smith JA. McAndrew J, et al. Histochem J. 1994 Apr;26(4):355-66. doi: 10.1007/BF00157769. Histochem J. 1994. PMID: 8040008

4

Prognostic significance of cathepsin-D in patients with breast cancer.

Winstanley JH, Leinster SJ, Cooke TG, Westley BR, Platt-Higgins AM, Rudland PS. Winstanley JH, et al. Br J Cancer. 1993 Apr;67(4):767-72. doi: 10.1038/bjc.1993.139. Br J Cancer. 1993. PMID: 8471433 Free PMC article.

5

Cytoplasmic staining of c-erbB-2 is not associated with the presence of detectable c-erbB-2 mRNA in breast cancer specimens.

Taylor SL, Platt-Higgins A, Rudland PS, Winstanley JH, Barraclough R. Taylor SL, et al. Int J Cancer. 1998 May 18;76(4):459-63. doi: 10.1002/(sici)1097-0215(19980518)76:4<459::aid-ijc2>3.0.co;2-q. Int J Cancer. 1998. PMID: 9590117

6

Human S100A4 (p9Ka) induces the metastatic phenotype upon benign tumour cells.

Lloyd BH, Platt-Higgins A, Rudland PS, Barraclough R. Lloyd BH, et al. Oncogene. 1998 Jul 30;17(4):465-73. doi: 10.1038/sj.onc.1201948. Oncogene. 1998. PMID: 9696040

7

Development of hyperplasias, preneoplasias, and mammary tumors in MMTV-c-erbB-2 and MMTV-TGFalpha transgenic rats.

Davies BR, Platt-Higgins AM, Schmidt G, Rudland PS. Davies BR, et al. Am J Pathol. 1999 Jul;155(1):303-14. doi: 10.1016/s0002-9440(10)65124-3. Am J Pathol. 1999. PMID: 10393862 Free PMC article.

8

Prognostic significance of the metastasis-inducing protein S100A4 (p9Ka) in human breast cancer.

Rudland PS, Platt-Higgins A, Renshaw C, West CR, Winstanley JH, Robertson L, Barraclough R. Rudland PS, et al. Cancer Res. 2000 Mar 15;60(6):1595-603. Cancer Res. 2000. PMID: 10749128

9

Comparison of the metastasis-inducing protein S100A4 (p9ka) with other prognostic markers in human breast cancer.

Platt-Higgins AM, Renshaw CA, West CR, Winstanley JH, De Silva Rudland S, Barraclough R, Rudland PS. Platt-Higgins AM, et al. Int J Cancer. 2000 Mar 20;89(2):198-208. Int J Cancer. 2000. PMID: 10754500

10

Variant estrogen receptor alpha mRNAs in human breast cancer specimens.

Anandappa SY, Sibson R, Platt-Higgins A, Winstanley JH, Rudland PS, Barraclough R. Anandappa SY, et al. Int J Cancer. 2000 Oct 15;88(2):209-16. doi: 10.1002/1097-0215(20001015)88:2<209::aid-ijc10>3.0.co;2-m. Int J Cancer. 2000. PMID: 11004670

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

39 results

Search Page

Filters